CLASS II ONGOING Device recall · Reported 1 Nov 2023 · FDA Enforcement Report

Journey II Bcs Constrained Articular Insert Size 5-6 Left recalled

Smith & Nephew is recalling Journey II Bcs Constrained Articular Insert Size 5-6 Left, distributed nationwide in the US. The recall was initiated on 27 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00885556176467, Batch Number 22BM17564
Quantity recalled29 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0158-2024
FDA event ID
93156
Recalling firm
Smith & Nephew, Memphis, TN
Classification
Class II
Status
Ongoing
Recall initiated
27 Sep 2023
FDA classified
24 Oct 2023
Reported
1 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Packaging Defects

Timeline

27 Sep 2023Recall initiated by company
24 Oct 2023Classified by FDA+27 days
1 Nov 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The JRNY II BCS XLPE ART ISRT SZ 5-6 LT 10MM was laser etched, labeled and packaged as a JRNY II BCS CNSTRD ART ISRT 5-6 LT 10MM. And also, a JRNY II BCS CNSTRD ART ISRT 5-6 LT 10MM was laser etched, labeled and packaged as a JRNY II BCS XLPE ART ISRT SZ 5-6 LT 10MM.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

JOURNEY II BCS CONSTRAINED ARTICULAR INSERT Size 5-6, 10 MM Left, REF 74029262; knee prosthesis

Where it was distributed

Worldwide distribution - US Nationwide and the country of Japan.

Nationwide

Questions about this recall

Why was it recalled?

The JRNY II BCS XLPE ART ISRT SZ 5-6 LT 10MM was laser etched, labeled and packaged as a JRNY II BCS CNSTRD ART ISRT 5-6 LT 10MM. And also, a JRNY II BCS CNSTRD ART ISRT 5-6 LT 10MM was laser etched, labeled and packaged as a JRNY II BCS XLPE ART ISRT SZ 5-6 LT 10MM.

Which lots are affected?

UDI/DI 00885556176467, Batch Number 22BM17564

Where was it sold?

Worldwide distribution - US Nationwide and the country of Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 93156

More recalls from Smith & Nephew

All 258

Other Hip & Knee Implants recalls

All 3,111